Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fidia Spa ( (IT:FDA) ) has provided an announcement.
Fidia S.p.A. has released its December 2025 monthly financial update under CONSOB’s enhanced transparency regime, detailing its net financial position, overdue debt exposures and related-party transactions for both the parent company and the Fidia Group. As of 31 December 2025, the company reported liquidity of €1.716 million and current financial indebtedness of €4.163 million, resulting in a net current financial debt position of €2.447 million, an improvement versus November 2025 and a significant reduction compared with year-end 2024 and 2023. The update also outlines regulatory requirements linked to its planned 2026 convertible bond with warrants reserved to Global Growth Holding Limited, confirming that the instrument has been approved by shareholders but not yet executed, and signals that Fidia will provide ongoing detail on subscription levels, conversions, fees and the alignment of this financing with its industrial and financial plans, information of particular relevance to creditors, investors and regulators monitoring the company’s capital-strengthening efforts and business continuity.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, operates in the industrial technology sector, applying international IFRS accounting standards and reporting regularly to the Italian securities regulator CONSOB under enhanced disclosure rules. The company reports consolidated and standalone financial data for the Fidia Group and is currently pursuing a capital-raising transaction via a convertible bond with warrants reserved to Global Growth Holding Limited and its affiliates, aimed at supporting its financial and industrial plans.
Average Trading Volume: 1,087,280
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.59M
For detailed information about FDA stock, go to TipRanks’ Stock Analysis page.